Dr. John T. Eagan Jr., MD

Dr. Eagan practices at Tria Vision-Colonnade in Birmingham, Alabama.

Dr. Eagan's NPI, 1881683365, was assigned on October 18, 2005. Dr. Eagan graduated from Heersink School of Medicine - Birmingham in 1986. Dr. Eagan's Alabama license number on file is 13380.

Dr. Eagan's primary practice is Tria Vision-Colonnade, at 3980 Colonnade Pkwy, Birmingham, AL 35243 in Jefferson County. The practice phone is (205) 876-8967.

Dr. Eagan's primary practice is Tria Vision-Colonnade in Birmingham, Alabama. Dr. Eagan is also affiliated with Grandview Medical Center. The medical group on file is Baptist Health Medical Group. Dmand AI also links Dr. Eagan to 4 more hospitals, 3 group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Eagan practices, 8 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Eagan's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Eagan is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Eagan's licenses on file in 3 states: Alabama, Arizona and Georgia.

Dmand AI lists aneurysm, angioplasty, arterial blot clot /embolism, atrial fibrillation and flutter, cardiac catheterization, cardiomyopathy, cerebrovascular disease and chest pain among the conditions Dr. Eagan treats.

CMS data shows 4,907 Medicare services from Dr. Eagan across 26 procedure codes in 2024, for 1,475 Medicare patients. Medicare paid $239,051 for them.

CMS counts 1,475 Medicare patients who saw Dr. Eagan in 2024. The largest group is 75 to 84, with 578 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.49, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Eagan's median patient age at 71, with 56% women.

In 2024, Dr. Eagan wrote 10,972 Medicare Part D claims for 1,285 patients. 84% of them were for generic drugs. CMS names the drug for 10,620 of them, across 68 drugs with 11 or more claims each, at $1,659,205 in total drug cost. In 2023, CMS named 9,127 claims across 66 drugs.

Dr. Eagan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Eagan as offering telehealth. CMS counts 60 procedures of varicose vein removal by Dr. Eagan, more than 77% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Eagan, published from 2010 to 2017. 2017 was the busiest year, with 2. The most frequent topics are Carcinoma, Basal Cell, Neoplasms, Radiation-Induced and Occupational Exposure. Dr. Eagan's most frequent co-author is Rachel Eshima McKay, MD.

CMS Open Payments shows 59 general payments to Dr. Eagan from 21 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 90% of the total. Janssen Pharmaceuticals, Inc paid the most, $24,005.

Dr. Eagan graduated from Heersink School of Medicine - Birmingham in 1986.

Dr. Eagan is in network with 17 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.